rethinkPeptides Search
Menu
Study breakdown

Two Blood Pressure-Lowering Peptides Identified from Tilapia Fish Skin Waste

evidence
The takeaway

Researchers identified two novel peptides from Nile tilapia skin gelatin that inhibit the blood pressure-regulating enzyme ACE and show antioxidant activity, offering potential natural alternatives from fish processing waste.

59.32% ACE inhibition

The most active peptide fraction from tilapia skin gelatin showed substantial ACE enzyme inhibition in laboratory tests

What the researchers found

Two peptides were identified from trypsin-digested Nile tilapia skin gelatin: GPEGPAGAR (810.87 Da) and GETGPAGPAGAAGPAGPR (1490.61 Da). The trypsin B fraction showed ACE inhibitory activity of 59.32 ± 9.97% and radical scavenging activity of 8.16 ± 2.18 µg trolox/mg peptide. The trypsin A fraction had the greatest reducing power at 5.138 ± 1.060 µM trolox/mg peptide.

Molecular docking analysis suggested the shorter peptide may fit slightly better into the ACE binding cleft, but both synthetic peptides showed no significant difference in ACE inhibitory activity in vitro, confirming their dual potential as antioxidant and antihypertensive agents.

Why it matters

High blood pressure affects over a billion people worldwide, and many patients seek natural alternatives to pharmaceutical ACE inhibitors. This study demonstrates that bioactive peptides with genuine ACE inhibitory activity can be extracted from fish processing waste — turning an environmental burden into a potentially valuable health product while supporting sustainability in the aquaculture industry.

How the study worked

Nile tilapia skin gelatin was digested with trypsin and the hydrolysate was purified by gel filtration chromatography. Fractions were tested for reducing power, radical scavenging activity, and ACE inhibition. The most active fraction was analyzed by MALDI-TOF/TOF mass spectrometry and identified using Mascot sequence matching. Peptide sequences were confirmed through molecular docking simulations against ACE and validated with in vitro ACE inhibition assays using synthetic versions of the identified peptides.

What this study cannot tell us

This is entirely an in vitro study with no animal or human testing of blood pressure effects. The ACE inhibition percentage (59.32%) was measured in a test tube and may not translate to meaningful blood pressure reduction when consumed orally, as the peptides may be further degraded during digestion. No bioavailability or pharmacokinetic data was provided. The study did not compare these peptides to existing ACE inhibitor drugs. Single-source material from one fish species limits generalizability.

How to read the evidence

This is an in vitro study combining biochemical fractionation, mass spectrometry identification, computational docking, and synthetic peptide validation. While the peptide identification is rigorous, no animal or human studies were conducted, placing this at a very early stage of evidence for any health claims.

When this study was published

Published in 2016, this study is nearly a decade old. The field of food-derived bioactive peptides has advanced significantly since then, with more studies now examining bioavailability and clinical effects.

The bigger picture

Food-derived bioactive peptides represent a growing field at the intersection of nutrition science and drug discovery. ACE inhibitory peptides from fish, milk, and other food sources could serve as functional food ingredients or nutraceuticals for blood pressure management. The use of fish skin waste as a source material also aligns with circular economy principles in food production.

Questions still open

  • Do these tilapia-derived peptides survive human digestion and reach the bloodstream in active form?
  • How do these peptides' ACE inhibitory potency compare to pharmaceutical ACE inhibitors like lisinopril?
  • Could these peptides be incorporated into functional foods or supplements for mild blood pressure management?

Common questions

Can eating fish skin lower blood pressure?
This study found peptides in tilapia skin that can inhibit ACE (a blood pressure-regulating enzyme) in lab tests. However, eating fish skin is very different from taking a purified peptide — the peptides may be broken down during digestion before they can have any effect. More research is needed to determine if these peptides survive digestion and actually lower blood pressure in people.
What is ACE and why is inhibiting it important for blood pressure?
ACE (angiotensin-I-converting enzyme) is an enzyme that produces a substance called angiotensin II, which tightens blood vessels and raises blood pressure. ACE inhibitor drugs are among the most commonly prescribed blood pressure medications. Finding natural peptides that also block this enzyme could lead to food-based supplements for people with mild hypertension.

Read the original research

Identification of bioactive peptide from Oreochromis niloticus skin gelatin.

Journal of food science and technology, 53(2), 1222-9

Citation

Choonpicharn, Sadabpong; Tateing, Suriya; Jaturasitha, Sanchai; Rakariyatham, Nuansri; Suree, Nuttee; Niamsup, Hataichanoke. (2016). Identification of bioactive peptide from Oreochromis niloticus skin gelatin.. Journal of food science and technology, 53(2), 1222-9. https://doi.org/10.1007/s13197-015-2091-x